Skip to main content
Fig. 1 | Malaria Journal

Fig. 1

From: A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine

Fig. 1

Individual drug concentration and its relationship with QTcF change from baseline when given as monotherapy and as combination; a for KAF156, b for PPQ. Open circles represent the monotherapy and cross marks represent the combination treatment. The dark gray and light gray shaded areas represent the 95% confidence interval for monotherapy and combination respectively

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us